{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:49:38Z","timestamp":1785854978488,"version":"3.56.0"},"reference-count":52,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"\n Background<\/jats:title>\n The rapid evolution of immunization programs in low- and middle-income countries (LMICs) has necessitated an augmentation of capacity for postlicensure vaccine safety monitoring.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study describes the protocol for establishing a Multicenter Active Adverse Events Following Immunization Surveillance System (MAASS) network in India, which conducted prospective observational surveillance for 12 adverse pediatric outcomes between November 1, 2017, and March 20, 2020.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A multistage site selection process was implemented, beginning with an initial screening survey followed by in-person visits to assess the suitability of potential tertiary care hospitals for inclusion in the network. We adopted a decentralized, collaborative approach to develop the study protocol, standardize case definitions, establish data collection procedures, and create a common data model for monitoring and analysis. Outcomes selected for surveillance included acute disseminated encephalomyelitis, anaphylaxis, aseptic meningitis, dengue, Guillain-Barr\u00e9 syndrome, Kawasaki disease, malaria, seizure, sepsis, thrombocytopenia, intussusception, and urinary tract infections. We screened all children aged 1-24 months who were hospitalized for more than 24 hours at participating sites to identify suspected or confirmed cases of these outcomes using a structured checklist. Written informed consent was obtained from the parent or legally authorized representative for inclusion in the study. Demographic, socioeconomic, and vaccine exposure information was collected for all included participants. Additional clinical information was gathered to assess the level of diagnostic certainty according to standardized case definitions. The study progressed through 3 distinct phases: network establishment (January-November 2017), active surveillance (November 2017-March 2020), and database analysis (April 2020-March 2024). The dissemination process is currently underway.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A geographically representative data network was established across 15 public and 7 private tertiary care hospitals in 17 states and 1 union territory in India. During the study period, we screened 90,147 age-eligible admissions and confirmed 8362 cases with study outcomes. Using multiple analytic study designs, we generated a database of outcomes and exposures to investigate associations between vaccine-event pairs of interest.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The MAASS network is unprecedented in its scope and scale among LMICs. While the study is specific to India, the lessons learned in establishing and implementing the network offer valuable insights for developing active surveillance systems and strengthening capacity for benefit-risk evaluations of vaccines in resource-constrained settings.<\/jats:p>\n <\/jats:sec>\n \n International Registered Report Identifier (IRRID)<\/jats:title>\n RR1-10.2196\/64050<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/64050","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T14:15:06Z","timestamp":1754662506000},"page":"e64050","source":"Crossref","is-referenced-by-count":0,"title":["Establishing a Multicenter Active Adverse Events Following Immunization Sentinel Surveillance Network Across 22 Tertiary Care Hospitals in India: Protocol for a Prospective Observational Study"],"prefix":"10.2196","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2166-401X","authenticated-orcid":false,"given":"Apoorva","family":"Sharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8559-5837","authenticated-orcid":false,"given":"Manoja Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1052-9708","authenticated-orcid":false,"given":"Akhil","family":"PM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7693-418X","authenticated-orcid":false,"given":"Ramesh","family":"Poluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9374-6511","authenticated-orcid":false,"given":"Neeraj Kumar","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5418-1984","authenticated-orcid":false,"given":"Christian","family":"Burri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9704-8315","authenticated-orcid":false,"given":"Jan","family":"Bonhoeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9635-8792","authenticated-orcid":false,"given":"Satinder","family":"Aneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9250-3366","authenticated-orcid":false,"given":"Deepak","family":"Polpakara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3008-8616","authenticated-orcid":false,"given":"Narendra Kumar","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MAASS Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2024.100485"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)01775-0"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2015.09.009"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-004898"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.05.027"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7015a2"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.05.018"},{"key":"ref8","unstructured":"LackritzESStergachisAndyStepanchakMariaMaternal immunization safety monitoring in low- and middle-income countries: a roadmap for program developmentBill & Melinda Gates Foundation and Global Alliance to Prevent Prematurity and Stillbirth (GAPPS)20172023-07-01https:\/\/www.gapps.org\/PDF\/MaternalImmunizationSafetyMonitoringInLMICs.pdf"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.07.013"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.07.035"},{"key":"ref11","unstructured":"World Health Organization (WHO)Global vaccine safety blueprintWHO20122023-07-01https:\/\/www.who.int\/docs\/default-source\/documents\/global-vaccine-safety-blueprint-1-2012.pdf"},{"key":"ref12","unstructured":"World Health Organization (WHO)Global Vaccine Safety Blueprint 2.0WHO2023-07-01https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/348966\/9789240036963-eng.pdf?sequence=1"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010643"},{"key":"ref14","unstructured":"Council for International Organization of Medical Sciences (CIOMS)CIOMS guide to active vaccine safety surveillance: report of the CIOMS working group on vaccine safetyCIOMS20172023-07-01https:\/\/cioms.ch\/wp-content\/uploads\/2020\/04\/240WEB-CIOMS-Guide-AVSS-20170202-protected.pdf"},{"key":"ref15","unstructured":"Indian Council of Medical Research (ICMR)National ethical guidelines for biomedical and health research involving human participantsICMR20172023-07-01https:\/\/ethics.ncdirindia.org\/asset\/pdf\/ICMR_National_Ethical_Guidelines.pdf"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/2224-3151.206931"},{"issue":"11","key":"ref17","first-page":"963","volume":"46","author":"Chaturvedi, S","year":"2009","journal-title":"Indian Pediatr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002594"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046827"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-020-02293-5"},{"key":"ref21","unstructured":"Indian Council of Medical Research (ICMR)National ethical guidelines for biomedical and health research involving human participantsICMR2023-07-01https:\/\/ethics.ncdirindia.org\/asset\/pdf\/ICMR_National_Ethical_Guidelines.pdf"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.10.013"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.01.016"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.060"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.058"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.02.064"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.003"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.09.016"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.09.025"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.09.008"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.02.067"},{"key":"ref32","author":"Kohl, Katrin S","year":"2005","journal-title":"Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology)"},{"key":"ref33","unstructured":"INCLENSomaarth I for demographic surveillanceINCLEN2023-07-01http:\/\/inclentrust.org\/inclen\/data-management-services\/"},{"key":"ref34","unstructured":"INCLENSomaarth-III, a tool for cross-sectional studies2023-07-01http:\/\/inclentrust.org\/inclen\/somaarth-3\/"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.11.012"},{"key":"ref36","author":"Kelsey, JL","year":"1996","journal-title":"Methods in Observational Epidemiology"},{"key":"ref37","unstructured":"StataCorpStata statistical software: release 15StataCorp LLC20172023-07-01https:\/\/www.stata.com\/stata15\/"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/26.4.404"},{"key":"ref39","unstructured":"AttriSTyagiAClimate profile of India: Contribution to the Indian Network of Climate Change Assessment (NATIONAL COMMUNICATION-II)Climate Change Cell, Odisha20102023-07-01https:\/\/climatechangecellodisha.org\/pdf\/Climate%20Profile%20of%20India.pdf"},{"key":"ref40","unstructured":"FryKFirestoneRChakrabortyNMMeasuring equity with nationally representative wealth quintilesPopulation Services International (PSI)20142023-07-01Washington DC, USAPopulation Services International (PSI)https:\/\/media.psi.org\/wp-content\/uploads\/2020\/02\/31012157\/Wealth-Quintile-Guide.pdf"},{"key":"ref41","unstructured":"National Family Health Survey (NFHS5), 2019-2021: India: Volume IIInternational Institute for Population Sciences (IIPS) and ICF20222023-07-01New Delhi, IndiaInternational Institute for Population Sciences (IIPS) and ICFhttps:\/\/dhsprogram.com\/pubs\/pdf\/FR375\/FR375.pdf"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2022.100160"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13060951"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.10.003"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.01.100"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000983"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.012"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2002276"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.09.019"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.020"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.07.085"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2100173"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2025\/1\/e64050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:56:52Z","timestamp":1785851812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2025\/1\/e64050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":52,"URL":"https:\/\/doi.org\/10.2196\/64050","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.64050","asserted-by":"object"}]},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}